| Product Code: ETC6752115 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Rare Disease Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Rare Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Rare Disease Treatment Market - Industry Life Cycle |
3.4 China Rare Disease Treatment Market - Porter's Five Forces |
3.5 China Rare Disease Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 China Rare Disease Treatment Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 China Rare Disease Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
4 China Rare Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on rare disease treatment |
4.2.2 Growing awareness and diagnosis of rare diseases in China |
4.2.3 Rising healthcare expenditure and investment in innovative treatments |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of rare disease treatments in China |
4.3.2 High cost associated with research and development of rare disease therapies |
5 China Rare Disease Treatment Market Trends |
6 China Rare Disease Treatment Market, By Types |
6.1 China Rare Disease Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Rare Disease Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 China Rare Disease Treatment Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 China Rare Disease Treatment Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.2 China Rare Disease Treatment Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 China Rare Disease Treatment Market Revenues & Volume, By Genetic Diseases, 2021- 2031F |
6.2.3 China Rare Disease Treatment Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.2.4 China Rare Disease Treatment Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.5 China Rare Disease Treatment Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.6 China Rare Disease Treatment Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.7 China Rare Disease Treatment Market Revenues & Volume, By Other, 2021- 2031F |
6.3 China Rare Disease Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 China Rare Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Rare Disease Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 China Rare Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China Rare Disease Treatment Market Import-Export Trade Statistics |
7.1 China Rare Disease Treatment Market Export to Major Countries |
7.2 China Rare Disease Treatment Market Imports from Major Countries |
8 China Rare Disease Treatment Market Key Performance Indicators |
8.1 Patient enrollment in rare disease clinical trials |
8.2 Number of approved rare disease treatments in China |
8.3 Funding and grants allocated for rare disease research and development in China |
9 China Rare Disease Treatment Market - Opportunity Assessment |
9.1 China Rare Disease Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 China Rare Disease Treatment Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 China Rare Disease Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
10 China Rare Disease Treatment Market - Competitive Landscape |
10.1 China Rare Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Rare Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here